Pineocytoma Overview

Save information for later
Sign Up

Learn About Pineocytoma

What is the definition of Pineocytoma?
A Pineocytoma is a tumor of the pineal gland, a small organ in the brain that makes melatonin (a sleep-regulating hormone). Signs and symptoms of Pineocytomas include headaches, nausea, hydrocephalus, vision abnormalities, and Parinaud syndrome. Pineocytomas are usually slow-growing and rarely spread to other parts of the body.
What are the alternative names for Pineocytoma?
  • Pineocytoma
  • Pinealocytoma
  • Pinealoma
Who are the top Pineocytoma Local Doctors?
Dr. Katherine B. Peters
Neurology
Dr. Katherine B. Peters
Neurology

Duke Health Integrated Practice Inc

2301 Erwin Rd, 
Durham, NC 
 68.2 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

Katherine Peters is a Neurologist in Durham, North Carolina. Dr. Peters and is rated as a Distinguished provider by MediFind in the treatment of Pineocytoma. Her top areas of expertise are Glioma, Astrocytoma, Gliomatosis Cerebri, and Brain Tumor. Dr. Peters is currently accepting new patients.

Dr. John P. Kirkpatrick
Radiation Oncology
Dr. John P. Kirkpatrick
Radiation Oncology

Duke Health Integrated Practice Inc

3400 Wake Forest Rd, Suite 310, 
Raleigh, NC 
 46.6 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

John Kirkpatrick is a Radiation Oncologist in Raleigh, North Carolina. Dr. Kirkpatrick and is rated as an Advanced provider by MediFind in the treatment of Pineocytoma. His top areas of expertise are Brain Tumor, Meningioma, Glioma, Astrocytoma, and Gamma Knife Radiosurgery. Dr. Kirkpatrick is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Annick Desjardins
Neurology | Neurosurgery
Dr. Annick Desjardins
Neurology | Neurosurgery

Duke Health Integrated Practice Inc

40 Duke Medicine Cir, 
Durham, NC 
 68.0 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

Annick Desjardins is a Neurologist and a Neurosurgery provider in Durham, North Carolina. Dr. Desjardins and is rated as an Experienced provider by MediFind in the treatment of Pineocytoma. Her top areas of expertise are Pediatric Low-Grade Glioma (pLGG), Atypical Teratoid Rhabdoid Tumor (ATRT), Neuroepithelioma, and Gliosarcoma. Dr. Desjardins is currently accepting new patients.

View All Doctors
What are the latest Pineocytoma Clinical Trials?
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification
Enrollment Status: Recruiting
Publish Date: January 03, 2025
Intervention Type: Other

Summary: Every new classification depends on its prognostic power and on the type of treatment given. With the rapid evolution of diagnostic methods and the advance in new treatments, there is much less reliable information available on how patients with newly defined brain tumour entities should be treated and what to expect from the current treatments. The goal is to determine whether the new 2021 WHO cl...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase 1 Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Phase 1 Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Who is this study for: Patients with diffuse intrinsic pontine glioma/Diffuse midline glioma and recurrent or refractory pediatric central nervous system tumors
Enrollment Status: Recruiting
Publish Date: December 11, 2024
Intervention Type: Biological
Study Drug: B7H3-specific chimeric antigen receptor T cell
Study Phase: Phase 1

Summary: This is a Phase 1 study of central nervous system (CNS) locoregional adoptive therapy with autologous CD4+ and CD8+ T cells lentivirally transduced to express a B7H3-specific chimeric antigen receptor (CAR) and EGFRt. CAR T cells are delivered via an indwelling catheter into the tumor resection cavity or ventricular system in children and young adults with diffuse intrinsic pontine glioma (DIPG), ...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center